Gene-editing technologies have opened a Pandora's box of possibilities for humanity. These innovations can fundamentally alter human cells and create transformations that range from insignificant to extraordinarily impactful. While such advancements hold immense promise for medical science and
The field of synthetic biology is experiencing rapid growth, merging principles from biology, engineering, chemistry, physics, and mathematics to unlock new potential in life sciences. At the forefront of this advancement is the University of Delaware (UD), where cutting-edge research is aimed at
African swine fever (ASF) is a highly contagious and deadly viral disease affecting both domesticated and wild pigs. With its widespread prevalence in areas such as Africa, Europe, Asia, and the Caribbean, this disease has significant economic implications. Recent estimates state that if ASF were
Roche has recently entered into a groundbreaking multi-year collaboration with Oxford BioTherapeutics (OBT), valued at over a billion dollars, to spearhead the development of novel antibody-based cancer treatments. This significant partnership focuses on the creation of innovative therapies such as
The notion of genetically engineering an unborn child's sexual orientation has stirred debates among ethicists, scientists, and religious groups. This discourse stems from the suggestion that, with advancements in scientific knowledge, it might be possible to determine an unborn child's
GRObio, a spinout from the George Church Lab at Harvard University, has encountered significant hurdles lately. Founded in 2016, GRObio focuses on developing therapeutic proteins built on nonstandard amino acids (NSAAs). Despite its pioneering approach, the company is undergoing a period of
